PEDIATRICS Vol. 98 No. 2 August 1996, pp. 196-200
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, C. L.
Right arrow Articles by Baxter, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, C. L.
Right arrow Articles by Baxter, B. D.

Influenza Vaccination of Children During Acute Asthma Exacerbation and Concurrent Prednisone Therapy

C. Lucy Park MD1, Arthur L. Frank MD1, Myrtis Sullivan MD, MPH2, Parveen Jindal MD2, and Barbara D. Baxter 3

1 Department of Pediatrics, University of Illinois at Chicago
2 Department of Pediatrics, Cook County Hospital, Chicago
3 Department of Microbiology and Immunology, Baylor College of Medicine, Houston

Objectives. The influenza vaccination rate is very low among children with moderate to severe asthma. This may be partly because of poor patient motivation and failure to visit clinics for vaccination. Another important factor may be health care providers' deferral of vaccination because of concern about the efficacy and safety of influenza vaccination during asthma exacerbations and concurrent prednisone therapy. We therefore examined the safety and immunogenicity of influenza vaccination during acute asthma exacerbation with concomitant prednisone therapy.

Setting. A pediatric allergy and pulmonology clinic and a pediatric emergency department.

Design. Children (n = 109) with a known diagnosis of asthma 6 months to 18 years of age were recruited. All participating patients, 59 without asthma symptoms (no prednisone, control group) and 50 with acute asthma exacerbation requiring prednisone burst therapy (prednisone group) received trivalent subvirion influenza vaccine. Fifteen children in the control group and 12 in the prednisone group received a booster dose according to American Academy of Pediatrics guidelines. Serum antibody titers to influenza A/Beijing/32/92 (H3N2), influenza A/Texas/36/91 (H1N1), and influenza B/Panama/45/90 were measured before and 2 weeks after vaccination. Adverse effects noted within 48 hours after vaccine dose were ascertained during the follow-up visit.

Results. The antibody response was analyzed by comparing mean postvaccine titers, the percentage of patients achieving protective antibody levels (ge5log2), and the percentage of patients achieving rises in titers of 2log2 or greater. Antibody responses to influenza A/Beijing/32/92 (H3N2) and influenza A/Texas/36/91 (H1N1) in the prednisone-treated and control groups were not different. A significantly better response to the influenza B/Panama/45/90 antigen was seen in the prednisone group for all three parameters. Children who received a booster dose and the subgroup of children with low prevaccination titers (le3log2) showed similar patterns. Adverse effects, including asthma exacerbation, local swelling at the injection site, fever, rash, and headache were not different in the two groups.

Submitted on July 17, 1995
Accepted on October 6, 1995




This article has been cited by other articles:


Home page
 PediatricsHome page
Committee on Infectious Diseases
Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007-2008
Pediatrics, April 1, 2008; 121(4): e1016 - e1031.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
T. Verstraeten, A. O. Jumaan, J. P. Mullooly, J. F. Seward, H. S. Izurieta, F. DeStefano, S. B. Black, and R. T. Chen
A Retrospective Cohort Study of the Association of Varicella Vaccine Failure With Asthma, Steroid Use, Age at Vaccination, and Measles-Mumps-Rubella Vaccination
Pediatrics, August 1, 2003; 112(2): e98 - 103.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
The American Lung Association Asthma Clinical Rese
The Safety of Inactivated Influenza Vaccine in Adults and Children with Asthma
N. Engl. J. Med., November 22, 2001; 345(21): 1529 - 1536.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
W. E P BEYER
Routine influenza vaccination for healthy children---old concept, new technologies
Arch. Dis. Child., December 1, 2000; 83(6): 461 - 462.
[Full Text]

Home page
 Arch Pediatr Adolesc MedHome page
M. P. Fairchok, D. P. Trementozzi, P. S. Carter, H. L. Regnery, and E. R. Carter
Effect of Prednisone on Response to Influenza Virus Vaccine in Asthmatic Children
Arch Pediatr Adolesc Med, December 1, 1998; 152(12): 1191 - 1195.
[Abstract] [Full Text] [PDF]